Joel Greenblatt's AXSM Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 980 shares of Axsome Therapeutics, Inc. (AXSM) worth $239,875, representing 0.00% of the portfolio. First purchased in 2019-Q2, this short-term holding has been held for 5 quarters.
Based on 13F filings, Joel Greenblatt has maintained this position in AXSM for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2019, adding 2,495 shares. Largest reduction occurred in Q3 2019, reducing 11,158 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Axsome Therapeutics (AXSM) Holding Value Over Time
Track share changes against reported price movement
Quarterly Axsome Therapeutics (AXSM) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +980 | New Buy | 980 | $244.77 |
| Q1 2020 | -2,495 | Sold Out | 0 | $0.00 |
| Q4 2019 | +2,495 | New Buy | 2,495 | $103.41 |
| Q3 2019 | -11,158 | Sold Out | 0 | $0.00 |
| Q2 2019 | +11,158 | New Buy | 11,158 | $25.72 |
Joel Greenblatt's Axsome Therapeutics Investment FAQs
Joel Greenblatt first purchased Axsome Therapeutics, Inc. (AXSM) in Q2 2019, acquiring 11,158 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Axsome Therapeutics, Inc. (AXSM) for 5 quarters since Q2 2019.
Joel Greenblatt's largest addition to Axsome Therapeutics, Inc. (AXSM) was in Q2 2019, adding 11,158 shares worth $287,000.
According to the latest 13F filing for Q2 2026, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 980 shares of Axsome Therapeutics, Inc. (AXSM), valued at approximately $239,875.
As of the Q2 2026 filing, Axsome Therapeutics, Inc. (AXSM) represents approximately 0.00% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in Axsome Therapeutics, Inc. (AXSM) was 11,158 shares, as reported at the end of Q2 2019.